Novartis Pharmaceuticals, based in East Hanover, N.J., has agreed to pay $422.5 million to settle allegations that it had illegally marketed its pharmaceutical drug Trileptal, filed false claims and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results